Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Novo Nordisk, the Danish pharmaceutical giant behind blockbuster diabetes drug Ozempic and its obesity counterpart Wegovy, is accelerating into uncharted territory with Amycretin, a dual-action peptide under Phase 3 trials ... Read More
Continuous Coverage
Dr. Priya Deshmukh | Senior Editor, Health | May 20, 2026 — A growing body of evidence suggests…
Fluffy Mayo Pancakes—a viral recipe from Allrecipes—are quietly reshaping home cooking culture, mirroring how viral food trends (like…
Virginia Cavaliers hire Cody Gougler as Deputy Athletics Director for External Operations, reshaping the ACC’s powerhouse front office…
A single repair shop in Boksburg, South Africa, fixes 1,000 PlayStation and Xbox consoles annually—a number that belies…
SpaceX (NYSE: SPX) filed confidential IPO paperwork on May 19, 2026, seeking a $1.75 trillion valuation that would…
The Australian Electoral Commission just delivered a blunt message to one of the country’s most controversial fringe groups:…
Global Affairs
CEVA Logistics, the Swiss-based global logistics giant owned by CMA CGM, has quietly expanded its footprint in Africa…
Markets And Money
SpaceX (ticker pending, Nasdaq-listed) has formally filed confidential documents with the U.S. Securities and Exchange Commission (SEC) to…
Digital Culture
Ugreen’s new Bluetooth tracker, the JT820, claims a staggering seven-year battery life on a single CR2032 coin cell—but…
Science And Wellbeing
After decades of widespread recommendation, a landmark review published this week in The BMJ concludes that calcium and…
Screen And Sound
French’s® has just unleashed its most chaotic collaboration yet—partnering with Illumination’s *Minions* and *Monsters* franchises to debut Goomi’s…
Fixtures And Form
NRL star Jai Arrow (Canberra Raiders) has revealed his battle with motor neurone disease (MND) has already impaired…
